27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Shares of Alexion Pharmaceuticals (NASDAQ:ALXN) moved higher by 6.7% in pre-market trading after the company reported Q3 results.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Quarterly Results
Earnings per share were up 16.13% year over year to $3.24, which beat the estimate of $2.58.
Revenue of $1,588,000,000 up by 25.73% from the same period last year, which beat the estimate of $1,420,000,000.
Outlook
The upcoming fiscal year's EPS expected to be between $11.70 and $12.00.
The upcoming fiscal year's revenue expected to be between $5,900,000,000 and $5,950,000,000.
Buy at this blue line for a shot at trading profitably
There are so many indicators out there on when to buy and sell. Nic uses none. He looks at a chart and buys when a stock “pushes” off this blue line. What blue line? Find out on the next page. It’ll change how you make money from stocks. Click here for the details.
How To Listen To The Conference Call
Date: Oct 29, 2020
Time: 09:00 AM
ET Webcast URL: https://ir.alexion.com/events-and-presentations
Recent Stock Performance
Company's 52-week high was at $128.57
52-week low: $72.67
Price action over last quarter: Up 19.52%
Company Description
Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.